Log in
Donate

Clinical Trial: SWOG LUNGMAP

SWOG LUNGMAP

Status: Open

NCT#03851445

A Master Protocol to Evaluate Biomarker-Driven Therapies and Immunotherapies in Previously-Treated Non-Small Cell Lung Cancer (Lung-MAP Screening Study)
A screening trial for  S1900A (closed), S1900C (closed), S1900E,   S1900G, and S1900K.

Eligible for screening study DCP 001

LUNGMAP participants with KRASG12c and TP53 mutations and Wild Type STK11, KEAP1, NFE2L2, AND CUL3 will no longer be assigned to S1900E, effective December 13, 2023.

Effective, June 30th, 2019, the sub-study S1400GEN is closed to accrual.

View All Clinical Trials
The Montana Cancer Consortium (MCC) is an independent nonprofit organization whose mission is to bring state-of-the-art cancer care to Montana, Idaho and Wyoming through National Cancer Institute (NCI) sponsored clinical research.

Navigation

About Us

Contact Us

Copyright © Montana Cancer Consortium | All rights reserved